The market for ophthalmic diagnostics equipment is anticipated to develop as the prevalence of eye conditions such age-related macular degeneration (AMD), cataracts, and diabetic retinopathy rises. For instance, glaucoma was the top cause of irreversible blindness in India on April 1, 2019, according to the Ministry of Health and Family Welfare (MoHFW), affecting at least 12 million people and leaving about 1.2 million of them blind. More than 90% of glaucoma cases are still undetected. The global market for ophthalmic diagnostics equipment is anticipated to develop over the course of the projected period as a result of rising rates of diabetes and eye conditions associated with it. For instance, as of November 10, 2021, 537 million persons (20-79 years) were living with diabetes, according to the World Health Organization (WHO). According to projections, there would be 643 million diabetics worldwide by 2030 and 783 million by 2045. In low- and middle-income nations, 3 out of 4 diabetic adults reside.
Coherent Market Insights estimates that the market for Ophthalmic Diagnostic Equipment is anticipated to reach US$ 2,502.6 million in 2022 and grow at a CAGR of 6.2% during the following five years (2022-2030).
Leading Companies in the Ophthalmic Diagnostic Equipment Industry:
Notal Vision, Inc
The company was founded in 2000 and has its headquarters in Manassas, Virginia. The mission of Notal Vision is to expand the management of eye diseases from the clinic to the home and enhance visual results. Notal Vision Inc. published two clinical studies in July 2022 that it claimed demonstrated the viability and effectiveness of their patient-operated, home-based optical coherence tomography (OCT) system for tracking wet age-related macular degeneration (AMD).
Topcon Corporation
The firm was founded in 1932 and has its main office in Tokyo, Japan. The business produces and sells projectors and other industrial items, as well as medical and measuring equipment largely used by ophthalmologists. VISIA Imaging S.r.l., a producer of ophthalmic devices with headquarters in a suburb of Florence, Italy, was purchased by Topcon Corporation in July 2021.
Bausch + Lomb
The business was established in 1853 and the business is headquartered in Laval, Canada. Optical products are developed, produced, and sold by Bausch & Lomb Incorporated. The company conducted an IPO in May 2022, at which point it resumed trading on a public market. Bausch + Lomb launched Improved PreserVision® AREDS 2 Formula Micro Soft Gels with OCUSorbTM in January 2023. The launch of Project Watson dog health care products in the US was announced by the company in october 2022.
